NASDAQ:UTHR - United Therapeutics Stock Price, Price Target & More

$109.77 -0.28 (-0.25 %)
(As of 04/25/2018 04:00 PM ET)
Previous Close$109.77
Today's Range$108.33 - $111.35
52-Week Range$106.30 - $152.55
Volume273,733 shs
Average Volume434,132 shs
Market Capitalization$4.82 billion
P/E Ratio10.08
Dividend YieldN/A
Beta1.34

About United Therapeutics (NASDAQ:UTHR)

United Therapeutics logoUnited Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening diseases worldwide. The company's commercial products include Remodulin, a continuously-infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhace the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also provides Unituxin for the treatment of pediatric patients with high-risk neuroblastoma who achieve a partial response to prior first-line multiagent multimodality therapy. In addition, the company develops implantable system for Remodulin; and the RemUnity system for delivery of intravenous and subcutaneous Remodulin; esuberaprost, RemoPro, and eNOS gene therapies for PAH; and organ transplantation-related technologies, including regenerative medicines, xenotransplantation, and ex-vivo lung perfusion. United Therapeutics Corporation was founded in 1996 and is headquartered in Silver Spring, Maryland.

Receive UTHR News and Ratings via Email

Sign-up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryBiotechnology
SectorMedical
SymbolNASDAQ:UTHR
CUSIP91307C10
Webwww.unither.com
Phone301-608-9292

Debt

Debt-to-Equity Ratio0.12%
Current Ratio3.26%
Quick Ratio3.01%

Price-To-Earnings

Trailing P/E Ratio10.08
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.73 billion
Price / Sales2.75
Cash Flow$11.8414 per share
Price / Cash9.27
Book Value$48.64 per share
Price / Book2.26

Profitability

EPS (Most Recent Fiscal Year)$10.89
Net Income$417.90 million
Net Margins24.22%
Return on Equity24.41%
Return on Assets17.67%

Miscellaneous

Employees800
Outstanding Shares43,240,000

How to Become a New Pot Stock Millionaire

United Therapeutics (NASDAQ:UTHR) Frequently Asked Questions

What is United Therapeutics' stock symbol?

United Therapeutics trades on the NASDAQ under the ticker symbol "UTHR."

How will United Therapeutics' stock buyback program work?

United Therapeutics announced that its Board of Directors has approved a stock buyback plan on Sunday, June 4th 2017, which authorizes the company to repurchase $250,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire up to 4.6% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its shares are undervalued.

How were United Therapeutics' earnings last quarter?

United Therapeutics Co. (NASDAQ:UTHR) announced its quarterly earnings data on Wednesday, February, 21st. The biotechnology company reported $3.89 EPS for the quarter, topping the Zacks' consensus estimate of $3.59 by $0.30. The biotechnology company earned $464.70 million during the quarter, compared to the consensus estimate of $420.55 million. United Therapeutics had a net margin of 24.22% and a return on equity of 24.41%. The firm's quarterly revenue was up 13.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.12 earnings per share. View United Therapeutics' Earnings History.

When is United Therapeutics' next earnings date?

United Therapeutics is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for United Therapeutics.

What price target have analysts set for UTHR?

8 equities research analysts have issued twelve-month price targets for United Therapeutics' shares. Their forecasts range from $95.00 to $232.00. On average, they anticipate United Therapeutics' stock price to reach $133.3750 in the next year. View Analyst Ratings for United Therapeutics.

What are Wall Street analysts saying about United Therapeutics stock?

Here are some recent quotes from research analysts about United Therapeutics stock:
  • 1. According to Zacks Investment Research, "United Therapeutics holds a strong position in the PAH market with four approved products targeting this indication. The company, at present, has many phase III programs in the fields of cardiopulmonary diseases and oncology. It is working on new delivery mechanisms for Remodulin and expanded indications for its other marketed products like Orenitram and Tyvaso, which might drive long-term growth. Several data read-outs and regulatory updates are expected in 2018. However, increased competitive pressure from Uptravi on its PAH drugs, mainly Orenitram, is a concern. We believe the company needs to use cash suitably to deal with generic competition for Remodulin that could materialize post Jun 2018. However, United Therapeutics’ shares have outperformed the industry in the past six months. Estimates have gone up ahead of the Q4 earnings release. The company has a mixed record of earnings surprises in the recent quarters. " (1/15/2018)
  • 2. Cowen Inc analysts commented, "1Q Revenues were weak across the prostacyclin PAH franchise." (4/26/2017)

Who are some of United Therapeutics' key competitors?

Who are United Therapeutics' key executives?

United Therapeutics' management team includes the folowing people:
  • Dr. Martine A. Rothblatt, Founder, Chairman & CEO (Age 63)
  • Mr. Michael I. Benkowitz, Pres & COO (Age 46)
  • Mr. James C. Edgemond, CFO & Treasurer (Age 50)
  • Mr. Paul A. Mahon, Exec. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Kevin Gray, Sr. VP of Strategic Operations & Logistics

Has United Therapeutics been receiving favorable news coverage?

News stories about UTHR stock have been trending somewhat positive recently, according to Accern. Accern rates the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. United Therapeutics earned a news impact score of 0.13 on Accern's scale. They also assigned media headlines about the biotechnology company an impact score of 45.98 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of United Therapeutics?

Shares of UTHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is United Therapeutics' stock price today?

One share of UTHR stock can currently be purchased for approximately $109.77.

How big of a company is United Therapeutics?

United Therapeutics has a market capitalization of $4.82 billion and generates $1.73 billion in revenue each year. The biotechnology company earns $417.90 million in net income (profit) each year or $10.89 on an earnings per share basis. United Therapeutics employs 800 workers across the globe.

How can I contact United Therapeutics?

United Therapeutics' mailing address is 1040 SPRING ST, SILVER SPRING MD, 20910. The biotechnology company can be reached via phone at 301-608-9292 or via email at [email protected]


MarketBeat Community Rating for United Therapeutics (UTHR)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  336 (Vote Outperform)
Underperform Votes:  446 (Vote Underperform)
Total Votes:  782
MarketBeat's community ratings are surveys of what our community members think about United Therapeutics and other stocks. Vote "Outperform" if you believe UTHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UTHR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

United Therapeutics (NASDAQ:UTHR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for United Therapeutics in the last 12 months. Their average twelve-month price target is $133.3750, suggesting that the stock has a possible upside of 21.50%. The high price target for UTHR is $232.00 and the low price target for UTHR is $95.00. There are currently 3 sell ratings, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 1.881.781.901.83
Ratings Breakdown: 3 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)		4 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)		3 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)		4 Sell Rating(s)
6 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $133.3750$132.4444$138.30$132.8182
Price Target Upside: 21.50% upside8.41% upside1.16% downside11.52% upside

United Therapeutics (NASDAQ:UTHR) Consensus Price Target History

Price Target History for United Therapeutics (NASDAQ:UTHR)

United Therapeutics (NASDAQ:UTHR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/3/2018Credit Suisse GroupUpgradeUnderperform -> Neutral$115.00HighView Rating Details
2/22/2018BarclaysReiterated RatingUnderweight -> Underweight$115.00 -> $105.00LowView Rating Details
1/5/2018OppenheimerBoost Price TargetOutperform$180.00LowView Rating Details
12/27/2017WedbushReiterated RatingOutperform -> Outperform$213.00 -> $232.00MediumView Rating Details
10/27/2017CowenReiterated RatingHold$129.00N/AView Rating Details
10/26/2017HC WainwrightReiterated RatingHold$95.00N/AView Rating Details
7/14/2017Jefferies GroupReiterated RatingSell$105.00LowView Rating Details
7/6/2017UBSReiterated RatingSell$106.00LowView Rating Details
4/11/2017JPMorgan ChaseSet Price TargetHold$125.00LowView Rating Details
2/23/2017Ladenburg ThalmannDowngradeBuy -> Neutral$145.00N/AView Rating Details
2/23/2017Leerink SwannBoost Price TargetMarket Perform$127.00 -> $148.00N/AView Rating Details
1/19/2017Standpoint ResearchDowngradeBuy -> HoldN/AView Rating Details
8/23/2016ArgusReiterated RatingHoldN/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

United Therapeutics (NASDAQ:UTHR) Earnings History and Estimates Chart

Earnings by Quarter for United Therapeutics (NASDAQ:UTHR)

United Therapeutics (NASDAQ:UTHR) Earnings Estimates

2018 EPS Consensus Estimate: $12.85
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$3.38$4.15$3.71
Q2 20183$2.82$4.81$3.68
Q3 20182$3.04$3.10$3.07
Q4 20182$1.81$2.95$2.38

United Therapeutics (NASDAQ UTHR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018N/AView Earnings Details
2/21/2018Q4 2017$3.59$3.89$420.55 million$464.70 millionViewN/AView Earnings Details
10/25/2017Q3 2017$4.01$6.27$426.43 million$445.50 millionViewN/AView Earnings Details
7/27/2017Q2 2017$3.61($1.25)$391.53 million$444.60 millionViewN/AView Earnings Details
4/26/2017Q1 2017$3.1250$3.89$399.59 million$370.50 millionViewN/AView Earnings Details
2/22/2017Q416$3.61$4.12$415.51 million$409.00 millionViewListenView Earnings Details
10/27/2016Q316$3.38$4.36$400.58 million$408.20 millionViewListenView Earnings Details
7/28/2016Q216$3.22$4.55$395.15 million$412.60 millionViewListenView Earnings Details
4/28/2016Q116$3.21$3.02$395.02 million$369.00 millionViewListenView Earnings Details
2/25/2016Q415$2.70$3.68$388.29 million$404.90 millionViewListenView Earnings Details
10/27/2015Q315$2.35$3.55$363.51 million$386.20 millionViewListenView Earnings Details
7/28/2015Q215$2.31$2.55$360.41 million$347.20 millionViewListenView Earnings Details
4/28/2015Q115$2.14$2.55$353.50 million$327.60 millionViewN/AView Earnings Details
2/24/2015Q414$2.03$3.21$336.22 million$346.40 millionViewN/AView Earnings Details
10/28/2014Q314$1.97$3.91$335.10 million$330.00 millionViewN/AView Earnings Details
7/29/2014Q214$1.75$2.57$308.04 million$322.80 millionViewN/AView Earnings Details
4/29/2014Q114$1.65$1.77$300.14 million$289.40 millionViewN/AView Earnings Details
2/25/2014Q413$1.51$2.88$295.43 million$289.02 millionViewN/AView Earnings Details
10/29/2013Q313$1.59$2.98$279.02 million$302.20 millionViewN/AView Earnings Details
7/25/2013Q2 2013$1.47$1.52$250.17 million$280.60 millionViewN/AView Earnings Details
4/25/2013Q1 2013$1.47$1.19$241.14 million$245.14 millionViewN/AView Earnings Details
2/26/2013Q4 2012$1.25$1.65$233.41 million$243.82 millionViewN/AView Earnings Details
11/1/2012Q312$1.26$2.82$227.63 million$242.50 millionViewN/AView Earnings Details
7/26/2012$1.23$1.34ViewN/AView Earnings Details
4/26/2012$1.00$1.32ViewN/AView Earnings Details
2/14/2012$0.85$0.77ViewN/AView Earnings Details
10/27/2011$0.88$1.32ViewN/AView Earnings Details
7/28/2011$0.49$1.27ViewN/AView Earnings Details
4/28/2011$0.64$1.29ViewN/AView Earnings Details
2/15/2011$0.62$0.15ViewN/AView Earnings Details
10/28/2010Q3 2010$0.54$0.66ViewN/AView Earnings Details
7/28/2010Q2 2010$0.45$0.62ViewN/AView Earnings Details
4/29/2010Q1 2010$0.30$0.32ViewN/AView Earnings Details
2/16/2010Q4 2009$0.28$0.16ViewN/AView Earnings Details
10/29/2009Q3 2009$0.34$0.21ViewN/AView Earnings Details
7/31/2009Q2 2009$0.28($0.05)ViewN/AView Earnings Details
5/1/2009Q1 2009$0.31$0.24ViewN/AView Earnings Details
2/17/2009Q4 2008$0.26$0.43ViewN/AView Earnings Details
10/30/2008Q3 2008$0.30$0.25ViewN/AView Earnings Details
7/31/2008Q2 2008$0.30$0.29ViewN/AView Earnings Details
5/1/2008Q1 2008$0.27$0.24ViewN/AView Earnings Details
2/19/2008Q4 2007$0.25$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

United Therapeutics (NASDAQ:UTHR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

United Therapeutics (NASDAQ UTHR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.80%
Insider Trading History for United Therapeutics (NASDAQ:UTHR)
Institutional Ownership by Quarter for United Therapeutics (NASDAQ:UTHR)

United Therapeutics (NASDAQ UTHR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/9/2018Martine A RothblattCEOSell21,513$110.88$2,385,361.4421,653View SEC Filing  
4/5/2018Martine A RothblattCEOSell21,512$114.30$2,458,821.6021,652View SEC Filing  
4/3/2018Martine A RothblattCEOSell22,059$114.44$2,524,431.96687View SEC Filing  
3/29/2018Martine A RothblattCEOSell43,024$111.14$4,781,687.3621,652View SEC Filing  
3/22/2018Martine A RothblattCEOSell1,100$110.01$121,011.001,240View SEC Filing  
3/20/2018Martine A RothblattCEOSell301$110.48$33,254.4821,652View SEC Filing  
3/16/2018Martine A RothblattCEOSell43,025$111.11$4,780,507.7521,652View SEC Filing  
3/14/2018Martine A RothblattCEOSell21,512$112.55$2,421,175.6021,652View SEC Filing  
12/8/2017Martine A RothblattCEOSell1$136.16$136.16141View SEC Filing  
12/7/2017Christopher CauseyDirectorSell580$134.72$78,137.601,555View SEC Filing  
11/30/2017Martine A RothblattCEOSell1,241$128.95$160,026.95View SEC Filing  
11/24/2017Martine A RothblattCEOSell1,253$124.07$155,459.71View SEC Filing  
11/16/2017Martine A RothblattCEOSell7,061$121.12$855,228.32View SEC Filing  
11/9/2017Martine A RothblattCEOSell1,260$121.46$153,039.601,400View SEC Filing  
11/6/2017Christopher CauseyDirectorSell580$122.00$70,760.002,135View SEC Filing  
11/2/2017Martine A RothblattCEOSell1,269$118.04$149,792.761,409View SEC Filing  
10/26/2017Martine A RothblattCEOSell1,263$120.38$152,039.941,403View SEC Filing  
10/19/2017Martine A RothblattCEOSell1,265$119.38$151,015.701,405View SEC Filing  
10/12/2017Martine A RothblattCEOSell1,263$120.20$151,812.60View SEC Filing  
10/5/2017Christopher CauseyDirectorSell580$122.00$70,760.00View SEC Filing  
10/5/2017Martine A RothblattCEOSell1,256$122.98$154,462.88View SEC Filing  
9/28/2017Martine A RothblattCEOSell1,265$119.70$151,420.502,334View SEC Filing  
9/21/2017Martine A RothblattCEOSell1,274$116.07$147,873.182,343View SEC Filing  
9/14/2017Martine A RothblattCEOSell1,258$122.08$153,576.642,327View SEC Filing  
9/7/2017Christopher CauseyDirectorSell580$134.48$77,998.403,295View SEC Filing  
9/7/2017Martine A RothblattCEOSell1,232$133.32$164,250.242,301View SEC Filing  
8/31/2017Martine A RothblattCEOSell1,235$130.49$161,155.152,304View SEC Filing  
8/24/2017Martine A RothblattCEOSell1,238$130.65$161,744.702,307View SEC Filing  
8/17/2017Martine A RothblattCEOSell1,235$131.95$162,958.252,304View SEC Filing  
8/10/2017Martine A RothblattCEOSell2,176$127.11$276,591.363,245View SEC Filing  
8/3/2017Martine A RothblattCEOSell1,248$126.41$157,759.682,317View SEC Filing  
7/27/2017Martine A RothblattCEOSell1,247$126.40$157,620.802,316View SEC Filing  
7/20/2017Martine A RothblattCEOSell1,236$131.62$162,682.321,376View SEC Filing  
7/13/2017Martine A RothblattCEOSell1,238$130.44$161,484.721,378View SEC Filing  
7/6/2017Christopher CauseyDirectorSell590$132.61$78,239.903,875View SEC Filing  
7/6/2017Martine A RothblattCEOSell1,234$132.29$163,245.861,374View SEC Filing  
7/5/2017Richard GiltnerDirectorSell3,490$131.12$457,608.80View SEC Filing  
6/29/2017Martine A RothblattCEOSell1,237$130.92$161,948.041,377View SEC Filing  
6/23/2017Raymond DwekDirectorSell3,490$131.71$459,667.90View SEC Filing  
6/22/2017Martine A RothblattCEOSell1,234$132.32$163,282.881,374View SEC Filing  
6/15/2017Martine A RothblattCEOSell1,238$130.20$161,187.601,378View SEC Filing  
6/8/2017Martine A RothblattCEOSell1,240$129.60$160,704.001,380View SEC Filing  
6/1/2017Martine A RothblattCEOSell1,251$125.02$156,400.021,391View SEC Filing  
5/25/2017Martine A RothblattCEOSell1,265$119.40$151,041.001,405View SEC Filing  
5/18/2017Martine A RothblattCEOSell1,261$120.72$152,227.921,401View SEC Filing  
5/11/2017Martine A RothblattCEOSell1,259$122.00$153,598.001,399View SEC Filing  
5/4/2017Martine A RothblattCEOSell1,258$122.24$153,777.921,398View SEC Filing  
4/27/2017Martine A RothblattCEOSell1,262$120.78$152,424.361,402View SEC Filing  
4/20/2017Martine A RothblattCEOSell1,260$121.14$152,636.401,400View SEC Filing  
4/13/2017Martine A RothblattCEOSell1,258$122.12$153,626.961,398View SEC Filing  
4/6/2017Martine A RothblattCEOSell1,257$122.39$153,844.231,397View SEC Filing  
3/30/2017Martine A RothblattCEOSell1,230$134.56$165,508.801,370View SEC Filing  
3/23/2017Martine A RothblattCEOSell1,219$139.33$169,843.271,359View SEC Filing  
3/22/2017Tommy G ThompsonDirectorSell2,000$139.37$278,740.002,000View SEC Filing  
3/16/2017Martine A RothblattCEOSell1,218$140.16$170,714.881,358View SEC Filing  
3/9/2017Martine A RothblattCEOSell1,206$146.72$176,944.321,346View SEC Filing  
3/2/2017Martine A RothblattCEOSell1,203$148.49$178,633.471,343View SEC Filing  
2/23/2017Martine A RothblattCEOSell1,208$145.16$175,353.281,348View SEC Filing  
2/16/2017Martine A RothblattCEOSell1,173$167.92$196,970.161,313View SEC Filing  
1/12/2017Christopher PatuskyDirectorSell5,000$141.99$709,950.005,000View SEC Filing  
1/12/2017Martine A RothblattCEOSell1,214$142.37$172,837.181,354View SEC Filing  
1/5/2017Martine A RothblattCEOSell1,208$145.73$176,041.841,348View SEC Filing  
12/29/2016Martine A RothblattCEOSell1,211$143.63$173,935.931,351View SEC Filing  
12/22/2016Martine A RothblattCEOSell1,218$140.23$170,800.141,358View SEC Filing  
12/15/2016Martine A RothblattCEOSell1,212$143.11$173,449.321,352View SEC Filing  
12/8/2016Martine A RothblattCEOSell1,236$131.78$162,880.081,376View SEC Filing  
12/6/2016Richard GiltnerDirectorSell5,000$133.37$666,850.005,000View SEC Filing  
12/1/2016Martine A RothblattCEOSell1,246$126.86$158,067.561,386View SEC Filing  
11/25/2016Martine A RothblattCEOSell1,233$132.81$163,754.731,373View SEC Filing  
11/17/2016Martine A RothblattCEOSell1,232$132.94$163,782.081,372View SEC Filing  
11/10/2016Christopher PatuskyDirectorSell5,000$131.42$657,100.005,000View SEC Filing  
11/10/2016Martine A RothblattCEOSell1,240$129.82$160,976.801,380View SEC Filing  
11/3/2016Martine A RothblattCEOSell1,272$116.94$148,747.681,412View SEC Filing  
10/27/2016Martine A RothblattCEOSell1,272$117.06$148,900.321,412View SEC Filing  
10/20/2016Martine A RothblattCEOSell1,282$113.30$145,250.601,422View SEC Filing  
10/13/2016Martine A RothblattCEOSell1,269$117.99$149,729.311,409View SEC Filing  
10/6/2016Martine A RothblattCEOSell1,260$121.17$152,674.201,400View SEC Filing  
9/29/2016Martine A RothblattCEOSell1,272$116.94$148,747.681,412View SEC Filing  
9/26/2016Tommy G ThompsonDirectorSell1,291$125.57$162,110.871,291View SEC Filing  
9/22/2016Martine A RothblattCEOSell1,249$125.87$157,211.631,389View SEC Filing  
9/15/2016Martine A RothblattCEOSell1,258$122.34$153,903.721,398View SEC Filing  
9/8/2016Martine A RothblattCEOSell1,254$123.44$154,793.761,394View SEC Filing  
9/1/2016Christopher PatuskyDirectorSell5,000$122.73$613,650.005,000View SEC Filing  
9/1/2016Martine A RothblattCEOSell1,257$122.81$154,372.171,397View SEC Filing  
8/25/2016Martine A RothblattCEOSell1,250$125.29$156,612.501,390View SEC Filing  
8/18/2016Martine A RothblattCEOSell1,249$125.88$157,224.121,389View SEC Filing  
8/11/2016Martine A RothblattCEOSell1,253$124.09$155,484.771,393View SEC Filing  
8/4/2016Martine A RothblattCEOSell1,249$125.78$157,099.221,389View SEC Filing  
7/28/2016Martine A RothblattCEOSell1,271$117.05$148,770.551,411View SEC Filing  
7/21/2016Martine A RothblattCEOSell1,284$112.77$144,796.681,424View SEC Filing  
7/14/2016Martine A RothblattCEOSell1,292$110.05$142,184.601,432View SEC Filing  
7/7/2016Martine A RothblattCEOSell1,293$109.87$142,061.911,433View SEC Filing  
6/30/2016Martine A RothblattCEOSell1,308$105.10$137,470.801,548View SEC Filing  
6/23/2016Martine A RothblattCEOSell1,312$104.07$136,539.841,552View SEC Filing  
6/16/2016Martine A RothblattCEOSell1,308$105.18$137,575.441,548View SEC Filing  
6/9/2016Martine A RothblattCEOSell1,277$114.99$146,842.231,517View SEC Filing  
6/8/2016Tommy G ThompsonDirectorSell2,000$115.62$231,240.002,000View SEC Filing  
6/2/2016Martine A RothblattCEOSell1,261$120.79$152,316.191,501View SEC Filing  
6/2/2016Raymond DwekDirectorSell3,000$118.82$356,460.003,000View SEC Filing  
5/26/2016Martine A RothblattCEOSell5,547$117.57$652,160.795,787View SEC Filing  
5/19/2016Martine A RothblattCEOSell5,546$110.75$614,219.505,786View SEC Filing  
5/12/2016Martine A RothblattCEOSell5,547$109.02$604,733.945,787View SEC Filing  
5/12/2016Raymond DwekDirectorSell3,000$110.00$330,000.003,000View SEC Filing  
5/5/2016Martine A RothblattCEOSell5,546$107.79$597,803.345,786View SEC Filing  
4/28/2016Martine A RothblattCEOSell5,547$106.81$592,475.075,787View SEC Filing  
4/21/2016Martine A RothblattCEOSell5,546$115.74$641,894.045,786View SEC Filing  
4/14/2016Martine A RothblattCEOSell5,547$114.32$634,133.045,787View SEC Filing  
4/7/2016Martine A RothblattCEOSell5,546$113.31$628,417.265,786View SEC Filing  
3/24/2016Martine A RothblattCEOSell5,546$110.80$614,496.805,786View SEC Filing  
3/17/2016Martine A RothblattCEOSell5,547$118.22$655,766.345,787View SEC Filing  
3/10/2016Martine A RothblattCEOSell5,546$123.41$684,431.865,786View SEC Filing  
3/3/2016Martine A RothblattCEOSell5,547$126.78$703,248.665,787View SEC Filing  
2/25/2016Martine A RothblattCEOSell5,546$122.45$679,107.705,786View SEC Filing  
2/18/2016Martine A RothblattCEOSell5,547$128.26$711,458.225,787View SEC Filing  
2/11/2016Martine A. RothblattCEOSell5,546$120.47$668,126.62240View SEC Filing  
2/4/2016Martine A. RothblattCEOSell5,547$122.13$677,455.11240View SEC Filing  
2/4/2016Raymond DwekDirectorSell3,000$122.66$367,980.00View SEC Filing  
1/28/2016Martine A. RothblattCEOSell5,546$124.00$687,704.00240View SEC Filing  
1/21/2016Martine A. RothblattCEOSell5,547$127.00$704,469.00240View SEC Filing  
1/14/2016Martine A. RothblattCEOSell5,546$135.94$753,923.24240View SEC Filing  
1/7/2016Martine A. RothblattCEOSell5,547$145.84$808,974.48240View SEC Filing  
1/7/2016Raymond DwekDirectorSell3,000$143.75$431,250.00View SEC Filing  
12/24/2015Martine A. RothblattCEOSell5,546$159.58$885,030.68240View SEC Filing  
12/17/2015Martine A. RothblattCEOSell5,546$158.49$878,985.54240View SEC Filing  
12/10/2015Martine A. RothblattCEOSell5,546$154.49$856,801.54240View SEC Filing  
12/3/2015Martine A. RothblattCEOSell5,546$154.49$856,801.54240View SEC Filing  
12/3/2015Raymond DwekDirectorSell3,000$157.22$471,660.00View SEC Filing  
11/27/2015Martine A. RothblattCEOSell5,561$153.81$855,337.41240View SEC Filing  
11/19/2015Martine A. RothblattCEOSell9,661$148.56$1,435,238.16240View SEC Filing  
11/12/2015Martine A. RothblattCEOSell4,115$147.72$607,867.80240View SEC Filing  
11/5/2015Martine A. RothblattCEOSell4,115$149.16$613,793.40240View SEC Filing  
11/5/2015Raymond DwekDirectorSell3,000$149.63$448,890.00View SEC Filing  
11/3/2015Richard GiltnerDirectorSell7,500$153.22$1,149,150.00View SEC Filing  
10/29/2015Martine A. RothblattCEOSell9,662$141.89$1,370,941.18240View SEC Filing  
10/28/2015Martine A. RothblattCEOSell2,211$136.58$301,978.38240View SEC Filing  
10/26/2015Martine A. RothblattCEOSell2,592$127.13$329,520.96240View SEC Filing  
10/22/2015Martine A. RothblattCEOSell9,662$122.40$1,182,628.80240View SEC Filing  
10/21/2015Martine A. RothblattCEOSell2,211$123.63$273,345.93240View SEC Filing  
10/19/2015Martine A. RothblattCEOSell2,592$126.71$328,432.32240View SEC Filing  
10/15/2015Martine A. RothblattCEOSell9,662$126.22$1,219,537.64240View SEC Filing  
10/14/2015Martine A. RothblattCEOSell2,211$123.53$273,124.83240View SEC Filing  
10/12/2015Martine A. RothblattCEOSell2,592$123.51$320,137.92240View SEC Filing  
10/8/2015Martine A. RothblattCEOSell9,662$122.48$1,183,401.76240View SEC Filing  
10/7/2015Martine A. RothblattCEOSell2,211$120.88$267,265.68240View SEC Filing  
10/5/2015Martine A. RothblattCEOSell2,592$126.88$328,872.96240View SEC Filing  
10/1/2015Martine A. RothblattCEOSell6,326$131.11$829,401.86240View SEC Filing  
10/1/2015Paul A. MahonEVPSell6,000$129.38$776,280.0035,054View SEC Filing  
10/1/2015Raymond DwekDirectorSell3,000$131.32$393,960.00View SEC Filing  
9/29/2015Martine A. RothblattCEOSell2,592$134.25$347,976.00240View SEC Filing  
9/29/2015Tommy G. ThompsonDirectorSell5,000$139.19$695,950.00View SEC Filing  
9/24/2015Martine A. RothblattCEOSell9,662$139.26$1,345,530.12240View SEC Filing  
9/23/2015Martine A. RothblattCEOSell2,211$142.05$314,072.55240View SEC Filing  
9/21/2015Martine A. RothblattCEOSell2,592$150.81$390,899.52240View SEC Filing  
9/17/2015Martine A. RothblattCEOSell9,662$152.02$1,468,817.24240View SEC Filing  
9/16/2015Martine A. RothblattCEOSell2,211$151.93$335,917.23240View SEC Filing  
9/14/2015Martine A. RothblattCEOSell2,592$153.08$396,783.36240View SEC Filing  
9/10/2015Martine A. RothblattCEOSell4,115$152.95$629,389.25240View SEC Filing  
9/9/2015Martine A. RothblattCEOSell2,211$152.77$337,774.47240View SEC Filing  
9/8/2015Martine A. RothblattCEOSell2,592$152.80$396,057.60240View SEC Filing  
9/3/2015Martine A. RothblattCEOSell9,662$153.67$1,484,759.54240View SEC Filing  
9/3/2015Raymond DwekDirectorSell3,000$155.54$466,620.00View SEC Filing  
9/2/2015Martine A. RothblattCEOSell2,211$151.12$334,126.32240View SEC Filing  
8/31/2015Martine A. RothblattCEOSell2,592$153.50$397,872.00240View SEC Filing  
8/27/2015Martine A. RothblattCEOSell9,662$160.37$1,549,494.94240View SEC Filing  
8/26/2015Martine A. RothblattCEOSell2,211$155.47$343,744.17240View SEC Filing  
8/24/2015Martine A. RothblattCEOSell2,592$155.36$402,693.12240View SEC Filing  
8/20/2015Martine A. RothblattCEOSell9,662$166.58$1,609,495.96240View SEC Filing  
8/19/2015Martine A. RothblattCEOSell2,211$167.13$369,524.43240View SEC Filing  
8/17/2015Martine A RothblattCEOSell2,592$166.61$431,853.12View SEC Filing  
8/13/2015Martine A RothblattCEOSell9,662$165.05$1,594,713.10View SEC Filing  
7/27/2015Martine A RothblattCEOSell2,592$166.38$431,256.96View SEC Filing  
7/23/2015Martine A RothblattCEOSell4,115$176.38$725,803.70View SEC Filing  
7/22/2015Martine A RothblattCEOSell2,211$174.55$385,930.05View SEC Filing  
7/20/2015Martine A RothblattCEOSell2,592$177.92$461,168.64View SEC Filing  
7/16/2015Martine A RothblattCEOSell9,662$175.51$1,695,777.62View SEC Filing  
7/15/2015Martine A RothblattCEOSell2,211$176.77$390,838.47View SEC Filing  
7/13/2015Martine A RothblattCEOSell2,592$172.42$446,912.64View SEC Filing  
7/9/2015Martine A RothblattCEOSell9,662$168.04$1,623,602.48View SEC Filing  
7/8/2015Martine A RothblattCEOSell2,211$167.13$369,524.43View SEC Filing  
7/6/2015Martine A RothblattCEOSell2,592$170.66$442,350.72View SEC Filing  
7/2/2015Martine A RothblattCEOSell6,326$170.69$1,079,784.94View SEC Filing  
7/2/2015Raymond DwekDirectorSell3,000$171.59$514,770.00View SEC Filing  
6/29/2015Martine A RothblattCEOSell2,592$172.86$448,053.12View SEC Filing  
6/25/2015Martine A RothblattCEOSell9,662$176.91$1,709,304.42View SEC Filing  
6/24/2015Martine A RothblattCEOSell2,211$179.68$397,272.48View SEC Filing  
6/22/2015Martine A RothblattCEOSell2,592$188.64$488,954.88View SEC Filing  
6/18/2015Louis W SullivanDirectorSell15,000$185.60$2,784,000.00View SEC Filing  
6/18/2015Martine A RothblattCEOSell9,662$185.72$1,794,426.64View SEC Filing  
6/17/2015Martine A RothblattCEOSell2,211$185.25$409,587.75View SEC Filing  
6/15/2015Martine A RothblattCEOSell2,592$185.15$479,908.80View SEC Filing  
6/11/2015Martine A RothblattCEOSell9,662$183.76$1,775,489.12View SEC Filing  
6/10/2015Martine A RothblattCEOSell2,211$180.87$399,903.57View SEC Filing  
6/8/2015Martine A RothblattCEOSell2,592$181.34$470,033.28View SEC Filing  
6/4/2015Martine A RothblattCEOSell9,662$181.94$1,757,904.28View SEC Filing  
6/4/2015Raymond DwekDirectorSell3,000$181.36$544,080.00View SEC Filing  
6/3/2015Martine A RothblattCEOSell2,211$184.49$407,907.39View SEC Filing  
6/1/2015Martine A RothblattCEOSell2,592$182.66$473,454.72View SEC Filing  
5/28/2015Martine A RothblattCEOSell9,662$180.88$1,747,662.56View SEC Filing  
5/27/2015Martine A RothblattCEOSell2,211$184.39$407,686.29View SEC Filing  
5/26/2015Martine A RothblattCEOSell2,592$182.64$473,402.88View SEC Filing  
5/21/2015Martine A RothblattCEOSell9,662$182.44$1,762,735.28View SEC Filing  
5/21/2015Tommy G ThompsonDirectorSell1,500$182.04$273,060.00View SEC Filing  
5/20/2015Martine A RothblattCEOSell2,211$182.80$404,170.80View SEC Filing  
5/18/2015Martine A RothblattCEOSell2,592$177.79$460,831.68View SEC Filing  
5/14/2015Martine A RothblattCEOSell9,662$174.07$1,681,864.34View SEC Filing  
5/13/2015Martine A RothblattCEOSell2,211$175.41$387,831.51View SEC Filing  
5/11/2015Martine A RothblattCEOSell2,592$179.55$465,393.60View SEC Filing  
5/7/2015Christopher CauseyDirectorSell1,500$167.94$251,910.00View SEC Filing  
5/7/2015Martine A RothblattCEOSell9,662$169.86$1,641,187.32View SEC Filing  
5/6/2015Martine A RothblattCEOSell2,211$169.22$374,145.42View SEC Filing  
5/4/2015Martine A RothblattCEOSell2,592$169.81$440,147.52View SEC Filing  
5/1/2015Raymond DwekDirectorSell3,000$159.58$478,740.00View SEC Filing  
4/30/2015Martine A RothblattCEOSell9,662$162.36$1,568,722.32View SEC Filing  
4/29/2015Martine A RothblattCEOSell2,211$164.29$363,245.19View SEC Filing  
4/28/2015Roger JeffsCEOSell5,000$163.31$816,550.00View SEC Filing  
4/27/2015Martine A RothblattCEOSell2,592$177.62$460,391.04View SEC Filing  
4/23/2015Martine A RothblattCEOSell9,662$187.35$1,810,175.70View SEC Filing  
4/22/2015Martine A RothblattCEOSell2,211$187.49$414,540.39View SEC Filing  
4/21/2015Roger JeffsCEOSell10,000$187.86$1,878,600.00View SEC Filing  
4/20/2015Martine A RothblattCEOSell2,592$184.86$479,157.12View SEC Filing  
4/16/2015Martine A RothblattCEOSell11,873$187.01$2,220,369.73View SEC Filing  
4/16/2015Paul A MahonEVPSell6,000$187.91$1,127,460.00View SEC Filing  
4/14/2015David ZaccardelliCOOSell3,250$185.82$603,915.00View SEC Filing  
4/14/2015Roger JeffsCEOSell10,000$185.82$1,858,200.00View SEC Filing  
4/13/2015Martine A RothblattCEOSell2,592$187.86$486,933.12View SEC Filing  
4/9/2015David ZaccardelliCOOSell4,000$184.84$739,360.00View SEC Filing  
4/9/2015Martine A RothblattCEOSell9,662$183.09$1,769,015.58View SEC Filing  
4/8/2015Martine A RothblattCEOSell2,211$181.91$402,203.01View SEC Filing  
4/7/2015David ZaccardelliCOOSell4,000$179.34$717,360.00View SEC Filing  
4/7/2015Roger JeffsCEOSell10,000$179.34$1,793,400.00View SEC Filing  
4/6/2015Martine A RothblattCEOSell2,592$176.20$456,710.40View SEC Filing  
4/2/2015David ZaccardelliCOOSell4,000$174.73$698,920.00View SEC Filing  
4/2/2015Martine A RothblattCEOSell11,873$173.43$2,059,134.39View SEC Filing  
4/2/2015Paul A MahonEVPSell6,000$174.73$1,048,380.00View SEC Filing  
4/2/2015Raymond DwekDirectorSell3,000$175.49$526,470.00View SEC Filing  
3/30/2015Martine A RothblattCEOSell2,592$177.22$459,354.24View SEC Filing  
3/26/2015David ZaccardelliCOOSell4,000$167.52$670,080.00View SEC Filing  
3/26/2015Martine A RothblattCEOSell9,662$167.03$1,613,843.86View SEC Filing  
3/25/2015Martine A RothblattCEOSell2,211$173.67$383,984.37View SEC Filing  
3/24/2015David ZaccardelliCOOSell4,500$179.51$807,795.00View SEC Filing  
3/23/2015Martine A RothblattCEOSell2,592$177.76$460,753.92View SEC Filing  
3/19/2015Paul A MahonEVPSell6,000$175.82$1,054,920.00View SEC Filing  
3/18/2015Martine A RothblattCEOSell2,211$174.64$386,129.04View SEC Filing  
3/17/2015David ZaccardelliCOOSell4,000$177.34$709,360.00View SEC Filing  
3/16/2015Martine A RothblattCEOSell2,592$170.97$443,154.24View SEC Filing  
3/12/2015Martine A RothblattCEOSell11,873$162.94$1,934,586.62View SEC Filing  
3/10/2015Roger JeffsCEOSell18,750$143.68$2,694,000.00View SEC Filing  
3/9/2015Martine A RothblattCEOSell2,592$160.51$416,041.92View SEC Filing  
3/5/2015Martine A RothblattCEOSell9,662$159.75$1,543,504.50View SEC Filing  
3/5/2015Raymond DwekDirectorSell3,000$157.59$472,770.00View SEC Filing  
3/4/2015Martine A RothblattCEOSell2,211$157.63$348,519.93View SEC Filing  
3/3/2015Roger JeffsCEOSell10,000$157.74$1,577,400.00View SEC Filing  
3/2/2015Martine A RothblattCEOSell2,592$155.32$402,589.44View SEC Filing  
2/27/2015Ray KurzweilDirectorSell15,000$155.05$2,325,750.00View SEC Filing  
2/26/2015Martine A RothblattCEOSell9,662$155.23$1,499,832.26View SEC Filing  
2/25/2015Martine A RothblattCEOSell2,211$159.35$352,322.85View SEC Filing  
2/24/2015David ZaccardelliCOOSell1,458$155.16$226,223.28View SEC Filing  
2/24/2015Roger JeffsCEOSell10,000$155.16$1,551,600.00View SEC Filing  
2/23/2015Martine A RothblattCEOSell2,592$156.08$404,559.36View SEC Filing  
2/19/2015John Maxim FerrariCFOSell10,000$155.72$1,557,200.00View SEC Filing  
2/19/2015Martine A RothblattCEOSell9,662$155.99$1,507,175.38View SEC Filing  
2/19/2015Paul A MahonEVPSell6,000$155.72$934,320.00View SEC Filing  
2/17/2015David ZaccardelliCOOSell4,000$155.14$620,560.00View SEC Filing  
2/17/2015Martine A RothblattCEOSell2,592$152.28$394,709.76View SEC Filing  
2/12/2015Martine A RothblattCEOSell9,662$146.01$1,410,748.62View SEC Filing  
2/11/2015Martine A RothblattCEOSell2,211$147.29$325,658.19View SEC Filing  
2/10/2015David ZaccardelliCOOSell4,000$146.68$586,720.00View SEC Filing  
2/10/2015Roger JeffsCEOSell10,000$146.68$1,466,800.00View SEC Filing  
2/9/2015Martine A RothblattCEOSell2,592$143.32$371,485.44View SEC Filing  
2/5/2015John Maxim FerrariCFOSell10,000$141.92$1,419,200.00View SEC Filing  
2/5/2015Martine A RothblattCEOSell11,773$141.07$1,660,817.11View SEC Filing  
2/5/2015Paul A MahonEVPSell6,000$141.92$851,520.00View SEC Filing  
2/5/2015Raymond DwekDirectorSell3,000$140.41$421,230.00View SEC Filing  
2/3/2015David ZaccardelliCOOSell4,000$141.99$567,960.00View SEC Filing  
2/3/2015Roger JeffsCEOSell10,000$141.99$1,419,900.00View SEC Filing  
1/29/2015Martine A RothblattCEOSell9,662$143.29$1,384,467.98View SEC Filing  
1/28/2015Martine A RothblattCEOSell2,211$145.49$321,678.39View SEC Filing  
1/27/2015David ZaccardelliCOOSell4,000$147.19$588,760.00View SEC Filing  
1/27/2015Roger JeffsCEOSell10,000$147.19$1,471,900.00View SEC Filing  
1/26/2015Martine A RothblattCEOSell2,592$145.89$378,146.88View SEC Filing  
1/22/2015Martine A RothblattCEOSell11,873$146.76$1,742,481.48View SEC Filing  
1/20/2015David ZaccardelliCOOSell4,000$146.48$585,920.00View SEC Filing  
1/20/2015Martine A RothblattCEOSell2,592$145.06$375,995.52View SEC Filing  
1/15/2015John Maxim FerrariCFOSell22,500$137.84$3,101,400.00View SEC Filing  
1/15/2015Martine A RothblattCEOSell9,662$137.51$1,328,621.62View SEC Filing  
1/15/2015Paul A MahonEVPSell6,000$137.84$827,040.00View SEC Filing  
1/14/2015Martine A RothblattCEOSell2,211$135.18$298,882.98View SEC Filing  
1/13/2015David ZaccardelliCOOSell3,000$134.71$404,130.00View SEC Filing  
1/13/2015Roger JeffsCEOSell10,000$134.71$1,347,100.00View SEC Filing  
1/12/2015Martine A RothblattCEOSell2,592$132.00$342,144.00View SEC Filing  
1/8/2015Christopher PatuskyDirectorSell5,000$128.13$640,650.00View SEC Filing  
1/8/2015Martine A RothblattCEOSell9,662$128.31$1,239,731.22View SEC Filing  
1/7/2015Martine A RothblattCEOSell2,211$126.04$278,674.44View SEC Filing  
1/6/2015David ZaccardelliCOOSell3,000$124.93$374,790.00View SEC Filing  
1/6/2015Roger JeffsCEOSell7,500$124.93$936,975.00View SEC Filing  
1/5/2015Martine A RothblattCEOSell2,592$126.88$328,872.96View SEC Filing  
1/2/2015Christopher CauseyDirectorSell3,000$129.25$387,750.00View SEC Filing  
1/2/2015Martine A RothblattCEOSell9,662$126.53$1,222,532.86View SEC Filing  
1/2/2015Paul A MahonEVPSell6,000$127.73$766,380.00View SEC Filing  
12/31/2014Martine A RothblattCEOSell2,211$131.35$290,414.85View SEC Filing  
12/30/2014Roger JeffsCEOSell10,000$130.80$1,308,000.00View SEC Filing  
12/29/2014Martine A RothblattCEOSell2,592$131.75$341,496.00View SEC Filing  
12/26/2014Martine A RothblattCEOSell9,662$131.85$1,273,934.70View SEC Filing  
12/24/2014Martine A RothblattCEOSell2,211$130.35$288,203.85View SEC Filing  
12/23/2014Roger JeffsCOOSell10,000$127.82$1,278,200.00View SEC Filing  
12/22/2014Martine A RothblattCEOSell2,592$133.45$345,902.40View SEC Filing  
12/19/2014Christopher CauseyDirectorSell1,500$131.47$197,205.00View SEC Filing  
12/18/2014John Maxim FerrariCFOSell10,000$131.11$1,311,100.00View SEC Filing  
12/18/2014Martine A RothblattCEOSell9,662$129.06$1,246,977.72View SEC Filing  
12/18/2014Paul A MahonEVPSell10,750$130.03$1,397,822.50View SEC Filing  
12/17/2014Martine A RothblattCEOSell2,211$126.04$278,674.44View SEC Filing  
12/15/2014Martine A RothblattCEOSell2,592$129.75$336,312.00View SEC Filing  
12/11/2014Martine A RothblattCEOSell9,662$130.98$1,265,528.76View SEC Filing  
12/10/2014Martine A RothblattCEOSell2,211$132.77$293,554.47View SEC Filing  
12/9/2014Roger JeffsCOOSell10,000$134.80$1,348,000.00View SEC Filing  
12/8/2014Martine A RothblattCEOSell2,592$132.34$343,025.28View SEC Filing  
12/4/2014John Maxim FerrariCFOSell10,000$129.05$1,290,500.00View SEC Filing  
12/4/2014Martine A RothblattCEOSell11,873$131.32$1,559,162.36View SEC Filing  
12/4/2014Paul A MahonEVPSell11,000$129.92$1,429,120.00View SEC Filing  
12/4/2014Raymond DwekDirectorSell3,000$131.58$394,740.00View SEC Filing  
12/2/2014Roger JeffsCOOSell10,000$133.63$1,336,300.00View SEC Filing  
12/1/2014Martine A RothblattCEOSell2,592$132.92$344,528.64View SEC Filing  
11/28/2014Martine A RothblattCEOSell11,873$132.77$1,576,378.21View SEC Filing  
11/25/2014Roger JeffsCOOSell10,000$131.30$1,313,000.00View SEC Filing  
11/24/2014Martine A RothblattCEOSell2,592$130.72$338,826.24View SEC Filing  
11/21/2014Roger JeffsCOOSell10,000$130.15$1,301,500.00View SEC Filing  
11/20/2014Christopher CauseyDirectorSell1,500$127.20$190,800.00View SEC Filing  
11/20/2014John Maxim FerrariCFOSell10,000$129.22$1,292,200.00View SEC Filing  
11/20/2014Martine A RothblattCEOSell9,662$128.86$1,245,045.32View SEC Filing  
11/20/2014Paul A MahonEVPSell11,000$129.02$1,419,220.00View SEC Filing  
11/19/2014Martine A RothblattCEOSell2,211$128.69$284,533.59View SEC Filing  
11/18/2014Roger JeffsCOOSell10,000$128.21$1,282,100.00View SEC Filing  
11/17/2014Martine A RothblattCEOSell2,592$125.65$325,684.80View SEC Filing  
11/13/2014Martine A RothblattCEOSell9,662$124.79$1,205,720.98View SEC Filing  
11/12/2014Martine A RothblattCEOSell2,211$122.88$271,687.68View SEC Filing  
11/10/2014Martine A RothblattCEOSell2,592$125.14$324,362.88View SEC Filing  
11/7/2014Christopher PatuskyDirectorSell5,000$124.49$622,450.00View SEC Filing  
11/7/2014Roger JeffsCOOSell10,000$124.46$1,244,600.00View SEC Filing  
11/6/2014Christopher CauseyDirectorSell1,500$122.89$184,335.00View SEC Filing  
11/6/2014Martine A RothblattCEOSell4,115$125.33$515,732.95View SEC Filing  
11/6/2014Paul A MahonEVPSell5,000$125.02$625,100.00View SEC Filing  
11/5/2014Martine A RothblattCEOSell2,211$124.31$274,849.41View SEC Filing  
11/3/2014Martine A RothblattCEOSell2,592$127.49$330,454.08View SEC Filing  
10/30/2014Martine A RothblattCEOSell9,662$130.42$1,260,118.04View SEC Filing  
10/29/2014Martine A RothblattCEOSell2,211$131.10$289,862.10View SEC Filing  
10/27/2014Martine A RothblattCEOSell2,592$132.16$342,558.72View SEC Filing  
10/23/2014Martine A RothblattCEOSell11,873$129.97$1,543,133.81View SEC Filing  
10/23/2014Paul A MahonEVPSell11,000$127.04$1,397,440.00View SEC Filing  
10/13/2014Martine A RothblattCEOSell2,592$124.31$322,211.52View SEC Filing  
10/9/2014Martine A RothblattCEOSell9,662$129.97$1,255,770.14View SEC Filing  
10/9/2014Paul A MahonEVPSell5,000$130.59$652,950.00View SEC Filing  
10/8/2014Martine A RothblattCEOSell2,211$131.50$290,746.50View SEC Filing  
10/7/2014Roger JeffsCOOSell35,000$130.14$4,554,900.00View SEC Filing  
10/6/2014Martine A RothblattCEOSell2,592$129.32$335,197.44View SEC Filing  
10/3/2014Roger JeffsCOOSell10,000$129.79$1,297,900.00View SEC Filing  
10/2/2014Christopher CauseyDirectorSell1,500$130.65$195,975.00View SEC Filing  
10/2/2014John Maxim FerrariCFOSell10,000$129.46$1,294,600.00View SEC Filing  
10/2/2014Martine A RothblattCEOSell9,662$127.72$1,234,030.64View SEC Filing  
10/2/2014Paul A MahonEVPSell6,000$129.46$776,760.00View SEC Filing  
10/1/2014Martine A RothblattCEOSell2,211$127.40$281,681.40View SEC Filing  
9/30/2014Roger JeffsCOOSell20,000$128.65$2,573,000.00View SEC Filing  
9/25/2014Martine A RothblattCEOSell5,547$134.26$744,740.22View SEC Filing  
9/25/2014Paul A MahonEVPSell5,000$133.77$668,850.00View SEC Filing  
9/25/2014Richard GiltnerDirectorSell20,000$134.94$2,698,800.00View SEC Filing  
9/23/2014Roger JeffsCOOSell50,000$131.02$6,551,000.00View SEC Filing  
9/19/2014Roger JeffsCOOSell10,000$129.60$1,296,000.00View SEC Filing  
9/18/2014John Maxim FerrariCFOSell10,000$130.93$1,309,300.00View SEC Filing  
9/18/2014Martine A RothblattCEOSell9,662$127.35$1,230,455.70View SEC Filing  
9/18/2014Paul A MahonEVPSell6,000$130.93$785,580.00View SEC Filing  
9/17/2014Roger JeffsCOOSell20,000$127.01$2,540,200.00View SEC Filing  
9/15/2014Martine A RothblattCEOSell50,000$124.52$6,226,000.00View SEC Filing  
9/11/2014Martine A RothblattCEOSell9,662$120.79$1,167,072.98View SEC Filing  
9/11/2014Paul A MahonEVPSell5,000$120.70$603,500.00View SEC Filing  
9/10/2014Martine A RothblattCEOSell50,000$120.01$6,000,500.00View SEC Filing  
9/10/2014Richard GiltnerDirectorSell20,000$119.95$2,399,000.00View SEC Filing  
9/5/2014Roger JeffsCOOSell10,000$111.29$1,112,900.00View SEC Filing  
9/4/2014John Maxim FerrariCFOSell10,000$112.38$1,123,800.00View SEC Filing  
9/4/2014Martine A RothblattCEOSell9,662$112.87$1,090,549.94View SEC Filing  
9/4/2014Paul A MahonEVPSell6,000$112.38$674,280.00View SEC Filing  
9/4/2014Raymond DwekDirectorSell3,000$113.40$340,200.00View SEC Filing  
8/28/2014Martine A RothblattCEOSell7,014$92.46$648,514.44View SEC Filing  
8/28/2014Paul A MahonEVPSell5,000$92.07$460,350.00View SEC Filing  
8/21/2014John Maxim FerrariCFOSell10,000$93.75$937,500.00View SEC Filing  
8/21/2014Martine A RothblattCEOSell9,640$93.13$897,773.20View SEC Filing  
8/15/2014Christopher CauseyDirectorSell1,500$91.14$136,710.00View SEC Filing  
8/14/2014Martine A RothblattCEOSell4,115$88.39$363,724.85View SEC Filing  
8/14/2014Paul A MahonEVPSell10,000$88.41$884,100.00View SEC Filing  
8/7/2014Christopher PatuskyDirectorSell5,000$88.23$441,150.00View SEC Filing  
8/7/2014John Maxim FerrariCFOSell10,000$86.44$864,400.00View SEC Filing  
8/7/2014Martine A RothblattCEOSell4,115$88.40$363,766.00View SEC Filing  
8/1/2014Raymond DwekDirectorSell3,000$89.52$268,560.00View SEC Filing  
8/1/2014Roger JeffsCOOSell10,000$89.88$898,800.00View SEC Filing  
7/31/2014Martine A RothblattCEOSell3,933$90.95$357,706.35View SEC Filing  
7/29/2014Roger JeffsCOOSell50,000$96.25$4,812,500.00View SEC Filing  
7/25/2014Roger JeffsCOOSell10,000$91.54$915,400.00View SEC Filing  
7/24/2014Martine A RothblattCEOSell9,228$93.15$859,588.20View SEC Filing  
7/17/2014John Maxim FerrariCFOSell10,000$89.74$897,400.00View SEC Filing  
7/17/2014Martine A RothblattCEOSell3,833$90.87$348,304.71View SEC Filing  
7/11/2014Roger JeffsCOOSell10,000$93.06$930,600.00View SEC Filing  
7/10/2014Martine A RothblattCEOSell9,187$92.33$848,235.71View SEC Filing  
7/3/2014Christopher CauseyDirectorSell1,500$91.62$137,430.00View SEC Filing  
7/3/2014John Maxim FerrariCFOSell10,000$90.58$905,800.00View SEC Filing  
7/3/2014Martine A RothblattCEOSell3,833$91.37$350,221.21View SEC Filing  
6/26/2014Martine A RothblattCEOSell3,833$87.23$334,352.59View SEC Filing  
6/20/2014Roger JeffsCOOSell10,000$87.00$870,000.00View SEC Filing  
6/19/2014John Maxim FerrariCFOSell10,000$87.02$870,200.00View SEC Filing  
6/19/2014Martine A RothblattCEOSell3,833$85.68$328,411.44View SEC Filing  
6/19/2014Paul A MahonEVPSell2,000$85.67$171,340.00View SEC Filing  
6/12/2014Martine A RothblattCEOSell9,066$98.22$890,462.52View SEC Filing  
6/10/2014Roger JeffsCOOSell10,000$96.29$962,900.00View SEC Filing  
6/9/2014Roger JeffsCOOSell10,000$96.32$963,200.00View SEC Filing  
6/5/2014Christopher CauseyDirectorSell1,500$96.48$144,720.00View SEC Filing  
6/5/2014Martine A RothblattCEOSell9,066$96.46$874,506.36View SEC Filing  
6/5/2014Paul A MahonEVPSell6,000$96.50$579,000.00View SEC Filing  
6/3/2014Roger JeffsCOOSell10,000$95.00$950,000.00View SEC Filing  
5/29/2014Martine A RothblattCEOSell9,066$95.27$863,717.82View SEC Filing  
5/27/2014Roger JeffsCOOSell10,000$99.14$991,400.00View SEC Filing  
5/22/2014Louis SullivanDirectorSell30,000$101.46$3,043,800.00View SEC Filing  
5/22/2014Martine RothblattCEOSell9,066$101.35$918,839.10140View SEC Filing  
5/20/2014Roger JeffsCOOSell10,000$99.91$999,100.001,234View SEC Filing  
5/16/2014Roger JeffsCOOSell10,000$100.00$1,000,000.001,234View SEC Filing  
5/15/2014John Maxim FerrariCFOSell10,000$101.49$1,014,900.00407View SEC Filing  
5/15/2014Martine RothblattCEOSell9,066$100.88$914,578.08140View SEC Filing  
5/15/2014Paul MahonEVPSell6,000$100.86$605,160.0034,832View SEC Filing  
5/13/2014Roger JeffsCOOSell10,000$105.53$1,055,300.001,234View SEC Filing  
5/8/2014Christopher PatuskyDirectorSell5,000$107.17$535,850.00View SEC Filing  
5/8/2014Martine RothblattCEOSell9,066$107.83$977,586.78140View SEC Filing  
5/6/2014Roger JeffsCOOSell10,000$106.50$1,065,000.001,234View SEC Filing  
5/2/2014Roger JeffsCOOSell10,000$102.00$1,020,000.001,234View SEC Filing  
5/1/2014Christopher CauseyDirectorSell1,500$99.30$148,950.00733View SEC Filing  
5/1/2014John Maxim FerrariCFOSell10,000$102.20$1,022,000.00407View SEC Filing  
5/1/2014Martine RothblattCEOSell9,066$101.84$923,281.44140View SEC Filing  
5/1/2014Paul MahonEVPSell6,000$102.71$616,260.0034,832View SEC Filing  
4/29/2014Roger JeffsCOOSell10,000$95.00$950,000.001,234View SEC Filing  
4/24/2014Martine RothblattCEOSell9,066$92.45$838,151.70140View SEC Filing  
4/22/2014Roger JeffsCOOSell10,000$96.00$960,000.001,234View SEC Filing  
4/17/2014John Maxim FerrariCFOSell10,000$96.20$962,000.00407View SEC Filing  
4/17/2014Martine RothblattCEOSell9,066$98.48$892,819.68140View SEC Filing  
4/17/2014Paul MahonEVPSell6,000$98.37$590,220.0034,832View SEC Filing  
4/15/2014Roger JeffsCOOSell10,000$95.06$950,600.001,234View SEC Filing  
4/10/2014Martine RothblattCEOSell9,066$96.18$871,967.88140View SEC Filing  
4/8/2014Roger JeffsCOOSell10,000$95.00$950,000.001,234View SEC Filing  
4/4/2014Roger JeffsCOOSell10,000$93.22$932,200.001,234View SEC Filing  
4/3/2014Christopher CauseyDirectorSell1,500$95.67$143,505.00733View SEC Filing  
4/3/2014John Maxim FerrariCFOSell10,000$93.22$932,200.00407View SEC Filing  
4/3/2014Martine RothblattCEOSell9,066$93.74$849,846.84140View SEC Filing  
4/3/2014Paul MahonEVPSell6,000$93.10$558,600.0034,832View SEC Filing  
4/1/2014Roger JeffsCOOSell10,000$95.44$954,400.001,234View SEC Filing  
3/27/2014Martine RothblattCEOSell9,066$93.35$846,311.10140View SEC Filing  
3/25/2014Roger JeffsCOOSell10,000$95.64$956,400.001,234View SEC Filing  
3/21/2014Roger JeffsCOOSell10,000$93.84$938,400.001,234View SEC Filing  
3/20/2014Christopher CauseyDirectorSell1,500$96.04$144,060.00733View SEC Filing  
3/20/2014John Maxim FerrariCFOSell10,000$96.11$961,100.00407View SEC Filing  
3/20/2014Martine RothblattCEOSell9,065$96.76$877,129.40140View SEC Filing  
3/20/2014Paul MahonEVPSell6,000$96.81$580,860.0034,832View SEC Filing  
3/18/2014Roger JeffsCOOSell10,000$96.51$965,100.001,234View SEC Filing  
3/13/2014Martine RothblattCEOSell3,833$95.64$366,588.12140View SEC Filing  
3/7/2014Roger JeffsCOOSell10,000$99.02$990,200.001,234View SEC Filing  
3/6/2014Christopher PatuskyDirectorSell5,000$101.39$506,950.00View SEC Filing  
3/6/2014John Maxim FerrariCFOSell10,000$99.07$990,700.00407View SEC Filing  
3/6/2014Martine RothblattCEOSell3,833$102.77$393,917.41140View SEC Filing  
3/6/2014Paul MahonEVPSell6,000$101.93$611,580.0034,832View SEC Filing  
2/28/2014Ray KurzweilDirectorSell15,000$101.42$1,521,300.00View SEC Filing  
2/27/2014Martine RothblattCEOSell3,833$100.68$385,906.44140View SEC Filing  
2/21/2014Roger JeffsCOOSell10,000$104.89$1,048,900.00897View SEC Filing  
2/20/2014Martine RothblattCEOSell3,833$103.91$398,287.03140View SEC Filing  
2/20/2014Paul MahonEVPSell6,000$104.63$627,780.0034,490View SEC Filing  
2/13/2014Martine RothblattCEOSell3,833$99.87$382,801.71140View SEC Filing  
2/7/2014Roger JeffsCOOSell10,000$96.61$966,100.00897View SEC Filing  
2/6/2014Martine RothblattCEOSell3,833$97.26$372,797.58140View SEC Filing  
2/6/2014Paul MahonEVPSell6,000$97.41$584,460.0034,490View SEC Filing  
2/6/2014Raymond DwekDirectorSell3,000$97.33$291,990.00View SEC Filing  
1/30/2014Martine RothblattCEOSell3,833$106.25$407,256.25140View SEC Filing  
1/23/2014Martine RothblattCEOSell3,833$111.78$428,452.74140View SEC Filing  
1/17/2014Roger JeffsCOOSell10,000$113.03$1,130,300.00897View SEC Filing  
1/16/2014Martine RothblattCEOSell3,833$111.21$426,267.93140View SEC Filing  
1/16/2014Paul MahonEVPSell6,000$111.98$671,880.0034,490View SEC Filing  
1/9/2014Christopher PatuskyDirectorSell5,000$110.00$550,000.00View SEC Filing  
1/9/2014Martine RothblattCEOSell3,833$108.35$415,305.55140View SEC Filing  
1/3/2014Roger JeffsCOOSell10,000$110.72$1,107,200.00897View SEC Filing  
1/2/2014Martine RothblattCEOSell3,833$111.54$427,532.82140View SEC Filing  
1/2/2014Paul MahonEVPSell6,000$110.78$664,680.0034,490View SEC Filing  
1/2/2014Raymond DwekDirectorSell3,000$111.41$334,230.00View SEC Filing  
12/31/2013Martine RothblattCEOSell18,140$112.64$2,043,289.60140View SEC Filing  
12/30/2013Martine RothblattCEOSell18,147$111.60$2,025,205.20140View SEC Filing  
12/27/2013Martine RothblattCEOSell18,147$113.15$2,053,333.05140View SEC Filing  
12/26/2013Martine RothblattCEOSell21,981$111.95$2,460,772.95140View SEC Filing  
12/24/2013Martine RothblattCEOSell18,149$114.05$2,069,893.45140View SEC Filing  
12/23/2013Martine RothblattCEOSell5,743$109.71$630,064.53140View SEC Filing  
12/20/2013Martine RothblattCEOSell18,149$86.72$1,573,881.28140View SEC Filing  
12/20/2013Roger JeffsCOOSell8,250$87.84$724,680.00897View SEC Filing  
12/19/2013Martine RothblattCEOSell21,982$86.73$1,906,498.86140View SEC Filing  
12/19/2013Paul MahonEVPSell6,000$86.45$518,700.0034,490View SEC Filing  
12/18/2013Martine RothblattCEOSell18,149$86.36$1,567,347.64140View SEC Filing  
12/17/2013Martine RothblattCEOSell12,251$86.49$1,059,588.99140View SEC Filing  
12/6/2013Roger JeffsCOOSell10,000$90.97$909,700.0019,760View SEC Filing  
12/5/2013Martine RothblattCEOSell3,833$89.79$344,165.07140View SEC Filing  
12/5/2013Paul MahonEVPSell6,000$89.18$535,080.0034,490View SEC Filing  
12/5/2013Raymond DwekDirectorSell3,000$90.13$270,390.00View SEC Filing  
11/21/2013Martine RothblattCEOSell3,833$92.49$354,514.17140View SEC Filing  
11/21/2013Paul MahonEVPSell6,000$92.47$554,820.0034,490View SEC Filing  
11/15/2013Roger JeffsCOOSell10,000$94.00$940,000.0019,760View SEC Filing  
11/14/2013Christopher PatuskyDirectorSell5,500$91.65$504,075.00View SEC Filing  
11/14/2013Martine RothblattCEOSell3,833$91.60$351,102.80140View SEC Filing  
11/7/2013Christopher PatuskyDirectorSell3,500$90.51$316,785.00View SEC Filing  
11/7/2013Martine RothblattCEOSell3,833$89.47$342,938.51140View SEC Filing  
11/7/2013Paul MahonEVPSell6,000$89.60$537,600.0034,490View SEC Filing  
11/1/2013Raymond DwekDirectorSell3,000$89.18$267,540.00View SEC Filing  
11/1/2013Roger JeffsCOOSell10,000$90.34$903,400.00View SEC Filing  
10/31/2013Martine A RothblattCEOSell3,833$86.89$333,049.37View SEC Filing  
10/24/2013Martine A RothblattCEOSell3,833$83.77$321,090.41View SEC Filing  
10/18/2013Roger JeffsCOOSell10,000$82.47$824,700.00View SEC Filing  
10/17/2013John Maxim FerrariCFOSell2,750$82.01$225,527.50View SEC Filing  
10/17/2013Martine A RothblattCEOSell3,833$81.84$313,692.72View SEC Filing  
10/17/2013Paul A MahonEVPSell6,000$81.79$490,740.00View SEC Filing  
10/10/2013Martine RothblattCEOSell3,833$82.58$316,529.14140View SEC Filing  
10/4/2013Roger JeffsCOOSell10,000$85.48$854,800.00View SEC Filing  
10/3/2013Christopher CauseyDirectorSell1,500$83.15$124,725.00View SEC Filing  
10/3/2013John Maxim FerrariCFOSell4,500$84.67$381,015.00View SEC Filing  
10/3/2013Martine A RothblattCEOSell3,833$84.20$322,738.60View SEC Filing  
10/3/2013Paul A MahonEVPSell6,000$84.38$506,280.00View SEC Filing  
9/26/2013Martine RothblattCEOSell3,833$78.41$300,545.53140View SEC Filing  
9/20/2013Roger JeffsCOOSell10,000$77.86$778,600.0019,760View SEC Filing  
9/19/2013John Maxim FerrariCFOSell4,500$78.67$354,015.00407View SEC Filing  
9/19/2013Martine RothblattCEOSell3,833$78.12$299,433.96140View SEC Filing  
9/19/2013Paul MahonEVPSell6,000$78.02$468,120.0034,490View SEC Filing  
9/12/2013Martine A RothblattCEOSell3,833$76.98$295,064.34View SEC Filing  
9/6/2013Roger JeffsCOOSell10,000$73.67$736,700.00View SEC Filing  
9/5/2013Christopher CauseyDirectorSell1,500$73.11$109,665.00View SEC Filing  
9/5/2013John Maxim FerrariCFOSell4,500$74.17$333,765.00View SEC Filing  
9/5/2013Martine A RothblattCEOSell3,833$73.63$282,223.79View SEC Filing  
9/5/2013Paul A MahonEVPSell6,000$73.29$439,740.00View SEC Filing  
8/29/2013Martine RothblattCEOSell3,833$72.76$278,889.08140View SEC Filing  
8/22/2013Martine RothblattCEOSell3,833$72.06$276,205.98140View SEC Filing  
8/16/2013Roger JeffsCOOSell10,000$71.21$712,100.0019,760View SEC Filing  
8/15/2013John Maxim FerrariCFOSell4,500$71.14$320,130.00View SEC Filing  
8/15/2013Martine RothblattCEOSell3,833$71.58$274,366.14140View SEC Filing  
8/15/2013Paul MahonEVPSell6,000$71.34$428,040.0034,490View SEC Filing  
8/8/2013Martine RothblattCEOSell3,833$73.11$280,230.63140View SEC Filing  
8/2/2013Roger JeffsCOOSell10,000$76.69$766,900.00View SEC Filing  
8/1/2013John Maxim FerrariCFOSell4,500$75.87$341,415.00View SEC Filing  
8/1/2013Martine A RothblattCEOSell3,833$75.97$291,193.01View SEC Filing  
8/1/2013Paul A MahonEVPSell6,000$75.91$455,460.00View SEC Filing  
8/1/2013Raymond DwekDirectorSell3,000$75.94$227,820.00View SEC Filing  
7/31/2013R Paul GrayDirectorSell7,500$74.93$561,975.00View SEC Filing  
7/25/2013Martine A RothblattCEOSell3,833$71.45$273,867.85View SEC Filing  
7/19/2013Roger JeffsCOOSell10,000$70.00$700,000.00View SEC Filing  
7/18/2013John Maxim FerrariCFOSell9,000$69.85$628,650.00View SEC Filing  
7/18/2013Martine A RothblattCEOSell3,833$68.96$264,323.68View SEC Filing  
7/18/2013Paul A MahonEVPSell6,000$69.15$414,900.00View SEC Filing  
7/11/2013Martine A RothblattCEOSell3,837$67.94$260,685.78View SEC Filing  
7/5/2013Christopher CauseyDirectorSell1,500$66.33$99,495.00View SEC Filing  
7/5/2013Martine A RothblattCEOSell3,863$67.28$259,902.64View SEC Filing  
7/5/2013Paul A MahonEVPSell6,000$67.04$402,240.00View SEC Filing  
7/5/2013Roger JeffsCOOSell10,000$67.21$672,100.00View SEC Filing  
6/21/2013Roger JeffsCOOSell10,000$63.34$633,400.00View SEC Filing  
6/20/2013John Maxim FerrariCFOSell4,500$63.22$284,490.00View SEC Filing  
6/20/2013Paul A MahonEVPSell6,000$63.29$379,740.00View SEC Filing  
6/7/2013Roger JeffsCOOSell10,000$67.00$670,000.00View SEC Filing  
6/6/2013John Maxim FerrariCFOSell4,500$64.84$291,780.00View SEC Filing  
6/6/2013Paul A MahonEVPSell6,000$63.84$383,040.00View SEC Filing  
6/6/2013Raymond DwekDirectorSell3,000$63.77$191,310.00View SEC Filing  
5/17/2013Roger JeffsCOOSell10,000$69.17$691,700.00View SEC Filing  
5/16/2013John Maxim FerrariCFOSell4,500$68.48$308,160.00View SEC Filing  
5/16/2013Paul A MahonEVPSell6,000$68.05$408,300.00View SEC Filing  
5/2/2013Paul A MahonEVPSell6,000$67.15$402,900.00View SEC Filing  
5/2/2013Raymond DwekDirectorSell3,000$66.75$200,250.00View SEC Filing  
4/11/2013Raymond DwekDirectorSell9,000$61.35$552,150.00View SEC Filing  
1/17/2013Paul A MahonEVPSell5,749$52.20$300,097.80View SEC Filing  
12/28/2012Martine A RothblattCEOBuy4,167$52.40$218,350.80View SEC Filing  
12/26/2012Martine A RothblattCEOBuy6,000$52.40$314,400.00View SEC Filing  
12/21/2012Martine A RothblattCEOBuy9,000$51.85$466,650.00View SEC Filing  
11/26/2012Christopher CauseyDirectorSell1,500$53.33$79,995.00View SEC Filing  
10/4/2012Christopher CauseyDirectorSell1,500$58.33$87,495.00View SEC Filing  
10/4/2012John Maxim FerrariCFOSell1,550$58.00$89,900.00View SEC Filing  
10/4/2012Paul A MahonEVPSell6,000$38.00$228,000.00View SEC Filing  
9/6/2012Christopher CauseyDirectorSell1,500$55.94$83,910.00View SEC Filing  
9/5/2012Christopher PatuskyDirectorSell2,000$55.47$110,940.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

United Therapeutics (NASDAQ UTHR) News Headlines

Source:
DateHeadline
Zacks: Brokerages Expect United Therapeutics Co. (UTHR) Will Announce Earnings of $4.23 Per ShareZacks: Brokerages Expect United Therapeutics Co. (UTHR) Will Announce Earnings of $4.23 Per Share
www.americanbankingnews.com - April 25 at 9:23 PM
United Therapeutics (UTHR) to Release Earnings on WednesdayUnited Therapeutics (UTHR) to Release Earnings on Wednesday
www.americanbankingnews.com - April 25 at 12:18 PM
United Therapeutics Corporation To Report First Quarter 2018 Financial Results Before The Market Opens On ...United Therapeutics Corporation To Report First Quarter 2018 Financial Results Before The Market Opens On ...
www.prnewswire.com - April 25 at 8:01 AM
United Therapeutics Corporation To Report First Quarter 2018 Financial Results Before The Market Opens On Wednesday, May 2, 2018United Therapeutics Corporation To Report First Quarter 2018 Financial Results Before The Market Opens On Wednesday, May 2, 2018
finance.yahoo.com - April 24 at 8:04 AM
Commit To Purchase United Therapeutics Corp At $100, Earn 12.5% Annualized Using OptionsCommit To Purchase United Therapeutics Corp At $100, Earn 12.5% Annualized Using Options
www.nasdaq.com - April 20 at 5:35 PM
United Therapeutics (UTHR) to Release Earnings on TuesdayUnited Therapeutics (UTHR) to Release Earnings on Tuesday
www.americanbankingnews.com - April 17 at 3:46 AM
United Therapeutics Co. (UTHR) CEO Martine A. Rothblatt Sells 21,513 SharesUnited Therapeutics Co. (UTHR) CEO Martine A. Rothblatt Sells 21,513 Shares
www.americanbankingnews.com - April 11 at 4:15 PM
Zacks: Analysts Expect United Therapeutics Co. (UTHR) Will Post Quarterly Sales of $397.50 MillionZacks: Analysts Expect United Therapeutics Co. (UTHR) Will Post Quarterly Sales of $397.50 Million
www.americanbankingnews.com - April 10 at 2:01 AM
$3.64 EPS Expected for United Therapeutics Co. (UTHR) This Quarter$3.64 EPS Expected for United Therapeutics Co. (UTHR) This Quarter
www.americanbankingnews.com - April 8 at 11:16 PM
Martine A. Rothblatt Sells 21,512 Shares of United Therapeutics Co. (UTHR) StockMartine A. Rothblatt Sells 21,512 Shares of United Therapeutics Co. (UTHR) Stock
www.americanbankingnews.com - April 6 at 4:17 PM
United Therapeutics buys two D.C. buildings for $6.5M for potential future expansionUnited Therapeutics buys two D.C. buildings for $6.5M for 'potential future expansion'
www.bizjournals.com - April 5 at 5:31 PM
Cowen Reaffirms Hold Rating for United Therapeutics (UTHR)Cowen Reaffirms Hold Rating for United Therapeutics (UTHR)
www.americanbankingnews.com - April 4 at 5:52 PM
United Therapeutics Co. (UTHR) Given Consensus Rating of "Hold" by AnalystsUnited Therapeutics Co. (UTHR) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - April 4 at 5:34 PM
Insider Selling: United Therapeutics Co. (UTHR) CEO Sells 22,059 Shares of StockInsider Selling: United Therapeutics Co. (UTHR) CEO Sells 22,059 Shares of Stock
www.americanbankingnews.com - April 4 at 4:19 PM
UPDATE: Credit Suisse Upgrades United Therapeutics Corp. (UTHR) to NeutralUPDATE: Credit Suisse Upgrades United Therapeutics Corp. (UTHR) to Neutral
www.streetinsider.com - April 4 at 8:01 AM
United Therapeutics Has Limited Downside Below $95 Level, Credit Suisse Says In UpgradeUnited Therapeutics Has Limited Downside Below $95 Level, Credit Suisse Says In Upgrade
www.msn.com - April 3 at 5:48 PM
United Therapeutics (UTHR) Upgraded by Credit Suisse Group to "Neutral"United Therapeutics (UTHR) Upgraded by Credit Suisse Group to "Neutral"
www.americanbankingnews.com - April 3 at 11:08 AM
How Did United Therapeutics Perform in 4Q17 and Fiscal 2017?How Did United Therapeutics Perform in 4Q17 and Fiscal 2017?
finance.yahoo.com - April 3 at 8:04 AM
How United Therapeutics’ Adcirca and Orenitram Performed in 2017How United Therapeutics’ Adcirca and Orenitram Performed in 2017
finance.yahoo.com - April 3 at 8:04 AM
Is United Therapeutics Corporation (NASDAQ:UTHR) A Financially Strong Company?Is United Therapeutics Corporation (NASDAQ:UTHR) A Financially Strong Company?
finance.yahoo.com - March 30 at 5:46 PM
Insider Selling: United Therapeutics Co. (UTHR) CEO Sells 43,024 Shares of StockInsider Selling: United Therapeutics Co. (UTHR) CEO Sells 43,024 Shares of Stock
www.americanbankingnews.com - March 30 at 4:14 PM
United Therapeutics (UTHR) Lowered to "Hold" at ValuEngineUnited Therapeutics (UTHR) Lowered to "Hold" at ValuEngine
www.americanbankingnews.com - March 25 at 12:54 AM
United Therapeutics (UTHR) Upgraded at BidaskClubUnited Therapeutics (UTHR) Upgraded at BidaskClub
www.americanbankingnews.com - March 24 at 6:46 PM
Why Is United Therapeutics (UTHR) Down 10.7% Since Its Last Earnings Report? - NasdaqWhy Is United Therapeutics (UTHR) Down 10.7% Since Its Last Earnings Report? - Nasdaq
www.nasdaq.com - March 24 at 8:35 AM
Why Is United Therapeutics (UTHR) Down 10.7% Since Its Last Earnings Report?Why Is United Therapeutics (UTHR) Down 10.7% Since Its Last Earnings Report?
finance.yahoo.com - March 23 at 6:01 PM
Martine A. Rothblatt Sells 1,100 Shares of United Therapeutics Co. (UTHR) StockMartine A. Rothblatt Sells 1,100 Shares of United Therapeutics Co. (UTHR) Stock
www.americanbankingnews.com - March 23 at 4:34 PM
Zacks: Brokerages Expect United Therapeutics Co. (UTHR) to Announce $3.64 EPSZacks: Brokerages Expect United Therapeutics Co. (UTHR) to Announce $3.64 EPS
www.americanbankingnews.com - March 22 at 11:08 PM
Insider Selling: United Therapeutics Co. (UTHR) CEO Sells 301 Shares of StockInsider Selling: United Therapeutics Co. (UTHR) CEO Sells 301 Shares of Stock
www.americanbankingnews.com - March 21 at 4:08 PM
Validea Benjamin Graham Strategy Daily Upgrade Report - 3/21 ... - NasdaqValidea Benjamin Graham Strategy Daily Upgrade Report - 3/21 ... - Nasdaq
www.nasdaq.com - March 21 at 8:16 AM
Investor Expectations to Drive Momentum within JELD-WEN Holding, Nathans Famous, Aerie Pharmaceuticals, RBC Bearings, Malibu Boats, and United Therapeutics — Discovering Underlying Factors of InfluenceInvestor Expectations to Drive Momentum within JELD-WEN Holding, Nathan's Famous, Aerie Pharmaceuticals, RBC Bearings, Malibu Boats, and United Therapeutics — Discovering Underlying Factors of Influence
finance.yahoo.com - March 21 at 8:16 AM
Should Value Investors Pick United Therapeutics (UTHR) Stock? - NasdaqShould Value Investors Pick United Therapeutics (UTHR) Stock? - Nasdaq
www.nasdaq.com - March 20 at 8:05 AM
Should Value Investors Pick United Therapeutics (UTHR) Stock?Should Value Investors Pick United Therapeutics (UTHR) Stock?
finance.yahoo.com - March 19 at 5:31 PM
Insider Selling: United Therapeutics Co. (UTHR) CEO Sells 43,025 Shares of StockInsider Selling: United Therapeutics Co. (UTHR) CEO Sells 43,025 Shares of Stock
www.americanbankingnews.com - March 16 at 7:14 PM
United Therapeutics (UTHR) Presents At 38th Annual Cowen And Company Healthcare Conference - SlideshowUnited Therapeutics (UTHR) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
seekingalpha.com - March 14 at 7:27 PM
Insider Selling: United Therapeutics Co. (UTHR) CEO Sells 21,512 Shares of StockInsider Selling: United Therapeutics Co. (UTHR) CEO Sells 21,512 Shares of Stock
www.americanbankingnews.com - March 14 at 7:11 PM
United Therapeutics Corporation To Present At Oppenheimer 28th Annual Healthcare Conference - PR Newswire (press release)United Therapeutics Corporation To Present At Oppenheimer 28th Annual Healthcare Conference - PR Newswire (press release)
www.prnewswire.com - March 14 at 8:05 AM
United Therapeutics Corporation To Present At Oppenheimer 28th Annual Healthcare ConferenceUnited Therapeutics Corporation To Present At Oppenheimer 28th Annual Healthcare Conference
finance.yahoo.com - March 14 at 8:05 AM
United Therapeutics Co. (UTHR) Given Consensus Rating of "Hold" by BrokeragesUnited Therapeutics Co. (UTHR) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 10 at 6:12 PM
United Therapeutics tries to reverse downtrend, up 6%United Therapeutics tries to reverse downtrend, up 6%
seekingalpha.com - March 8 at 7:03 PM
United Therapeutics Corporation To Present At Cowen And Company 38th Annual Health Care Conference - PR Newswire (press release)United Therapeutics Corporation To Present At Cowen And Company 38th Annual Health Care Conference - PR Newswire (press release)
www.prnewswire.com - March 7 at 8:00 AM
United Therapeutics Corporation To Present At Cowen And Company 38th Annual Health Care ConferenceUnited Therapeutics Corporation To Present At Cowen And Company 38th Annual Health Care Conference
finance.yahoo.com - March 7 at 8:00 AM
United Therapeutics Co. (UTHR) Expected to Announce Quarterly Sales of $397.50 MillionUnited Therapeutics Co. (UTHR) Expected to Announce Quarterly Sales of $397.50 Million
www.americanbankingnews.com - March 7 at 2:48 AM
United Therapeutics Co. (UTHR) Shares Bought by University of Notre Dame DU LacUnited Therapeutics Co. (UTHR) Shares Bought by University of Notre Dame DU Lac
www.americanbankingnews.com - March 6 at 12:07 PM
United Therapeutics Co. (UTHR) Shares Sold by UBS Asset Management Americas Inc.United Therapeutics Co. (UTHR) Shares Sold by UBS Asset Management Americas Inc.
www.americanbankingnews.com - March 5 at 9:42 AM
The Manufacturers Life Insurance Company Has $10.61 Million Holdings in United Therapeutics Co. (UTHR)The Manufacturers Life Insurance Company Has $10.61 Million Holdings in United Therapeutics Co. (UTHR)
www.americanbankingnews.com - March 3 at 8:34 AM
Standard Life Aberdeen plc Trims Stake in United Therapeutics Co. (UTHR)Standard Life Aberdeen plc Trims Stake in United Therapeutics Co. (UTHR)
www.americanbankingnews.com - March 2 at 8:26 PM
Q3 2018 EPS Estimates for United Therapeutics Co. Boosted by Wedbush (UTHR)Q3 2018 EPS Estimates for United Therapeutics Co. Boosted by Wedbush (UTHR)
www.americanbankingnews.com - March 2 at 11:32 AM
Blog Exposure - Cipher Pharma Acquired Canadian Rights to Synergy Pharma’s FDA-Approved TRULANCE(R)Blog Exposure - Cipher Pharma Acquired Canadian Rights to Synergy Pharma’s FDA-Approved TRULANCE(R)
finance.yahoo.com - March 2 at 8:00 AM
State of Wisconsin Investment Board Has $6.80 Million Position in United Therapeutics Co. (UTHR)State of Wisconsin Investment Board Has $6.80 Million Position in United Therapeutics Co. (UTHR)
www.americanbankingnews.com - March 1 at 6:04 PM
Burney Co. Purchases 3,499 Shares of United Therapeutics Co. (UTHR)Burney Co. Purchases 3,499 Shares of United Therapeutics Co. (UTHR)
www.americanbankingnews.com - March 1 at 5:26 AM

SEC Filings

United Therapeutics (NASDAQ:UTHR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

United Therapeutics (NASDAQ:UTHR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

United Therapeutics (NASDAQ UTHR) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.